We recently published a list of Billionaire Ken Fisher’s Top 13 Growth Stock Picks. In this article, we are going to take a ...

Musk’s arrival at the social platform has raised questions for users, which includes pharma companies who use Twitter for marketing and patients who utilise it to engage with their medical ...

We recently published a list of 10 Low Volatility Stocks to Buy According to Billionaire Ken Fisher In this article, we are ...

Merck plans to launch US subcutaneous version of Keytruda on October 1 Healthcare & Pharmaceuticalscategory · 12:15 AM UTC · Updated ago The Merck logo is seen at a gate to the Merck & Co ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

While you may be more familiar with brand names such as Ozempic or Wegovy, these drugs are known as glucagon-like peptide-1 (GLP-1) agonists in the medical world. Eli Lilly ( LLY -0.50%) has emerged ...

Eli Lilly and Novo Nordisk have scored big wins from the FDA in recent months, as the agency cracks down on copycat versions ...

In a report released on March 21, Umer Raffat from Evercore ISI maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report).

Top health care investment bankers say that large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...

LONDON, March 27 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as investor worries ...